Vincerx Pharma Inc.’s filing revealed that its insider Seelenberger Alexander A. acquired Company’s shares for reported $9968.0 on Aug 11. In the deal valued at $0.95 per share,10,500 shares were bought. As a result of this transaction, Seelenberger Alexander A. now holds 30,280 shares worth roughly $ 21498.8.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Hamdy Ahmed MD bought 5,400 shares, generating $5,167 in total proceeds. Upon buying the shares at $0.96, the insider now owns 96,060 shares.
Before that, THOMAS TOM C bought 5,000 shares. Vincerx Pharma Inc. shares valued at $4,750 were divested by the insider at a price of $0.95 per share. As a result of the transaction, THOMAS TOM C now holds 219,935 shares, worth roughly $0.16 million.
H.C. Wainwright initiated its Vincerx Pharma Inc. [VINC] rating to a Buy in a research note published on Friday, January 14, 2022; the price target was $25. PT values the company’s stock at a premium of 97.16 to its Friday closing price.
Price Performance Review of VINC
On Friday, Vincerx Pharma Inc. [NASDAQ:VINC] saw its stock jump 7.83% to $0.71. On the same session, the stock had its day’s lowest price of $0.67, but rose to a high of $0.758. Over the last five days, the stock has lost -1.15%. Vincerx Pharma Inc. shares have fallen nearly -30.23% since the year began. Nevertheless, the stocks have fallen -53.18% over the past one year. While a 52-week high of $1.95 was reached on 06/07/23, a 52-week low of $0.63 was recorded on 08/31/23. SMA at 50 days reached $1.0568, while 200 days put it at $1.1442. A total of 92821.0 shares were traded, compared to the trading of 0.14 million shares in the previous session.
Levels Of Support And Resistance For VINC Stock
The 24-hour chart illustrates a support level at 0.6685, which if violated will result in even more drops to 0.6252. On the upside, there is a resistance level at 0.7565. A further resistance level may holdings at 0.8012. The Relative Strength Index (RSI) on the 14-day chart is 34.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0981, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.30%. Stochastics %K at 12.14% indicates the stock is a buying.
How much short interest is there in Vincerx Pharma Inc.?
A steep rise in short interest was recorded in Vincerx Pharma Inc. stocks on Aug 14, 2023, dropping by 14150.0 shares to a total of 0.11 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.12 million shares. There was a decline of -13.36%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.68% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.66.
Vincerx Pharma Inc. [VINC] – Who Are The Largest Shareholders?
In filings from Goldman Sachs & Co. LLC, it is revealed that the company now owns 2,062,950 shares, or roughly 9.71% of the outstanding VINC shares. In other words, the investor’s shares have fallen by -1,942 from its previous 13-F filing of 2064892.0.. Over the last quarter, Long Focus Capital Management LLC sold -316,198 shares of Vincerx Pharma Inc., while Rock Springs Capital Management L sold 0 shares. At present, Citadel Advisors LLC is holding 623,927 shares valued at $0.67 million. Schonfeld Strategic Advisors LLC owned 601,645 shares of the company at the time of its most recent 13F filing, worth $0.65 million.
According to FactSet, Vincerx Pharma Inc.’s share price will average $6.33 in the next year, based on opinions of analysts polled by the firm. This is up nearly 657.58 percent from its previous closing price of $0.66. Analysts expect Vincerx Pharma Inc. stock to reach the higher price of $10.00, while the lowest price estimate is $4.00. However, 3 analysts have rated VINC stock as a Buy in their predictions for 2023.